Literature DB >> 15053453

Assessment of radiographs in longitudinal observational studies.

Désirée M F M van der Heijde1.   

Abstract

Radiographs are important to assess structural damage in longitudinal studies. This article describes several issues on the selection of films, frequency of followup, scoring of radiographs, and presentation of results, especially in the context of longitudinal studies.

Mesh：

Year:  2004        PMID： 15053453

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


  6 in total

1.  The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.

Authors:  A Kavanaugh; C E Antoni; D Gladman; S Wassenberg; B Zhou; A Beutler; G Keenan; G Burmester; D E Furst; M H Weisman; J R Kalden; J Smolen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

2.  Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs.

Authors:  Haruko Ideguchi; Shigeru Ohno; Hideaki Hattori; Akiko Senuma; Yoshiaki Ishigatsubo
Journal:  Arthritis Res Ther       Date:  2006-04-28       Impact factor: 5.156

3.  Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis.

Authors:  Yinghe Huo; Maria J H De Hair; Yasmin O Shaib; Désirée van der Heijde; Natalia O Kuchuk; Max A Viergever; Jacob M van Laar; Koen L Vincken; Floris P Lafeber
Journal:  RMD Open       Date:  2015-12-09

Review 4.  Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis-a comprehensive review.

Authors:  Paul Emery; Patrick Durez; Axel J Hueber; Inmaculada de la Torre; Esbjörn Larsson; Thorsten Holzkämper; Yoshiya Tanaka
Journal:  Arthritis Res Ther       Date:  2021-01-04       Impact factor: 5.156

5.  Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.

Authors:  Maxime Dougados; Désirée van der Heijde; Ying-Chou Chen; Maria Greenwald; Edit Drescher; Jiajun Liu; Scott Beattie; Sarah Witt; Inmaculada de la Torre; Carol Gaich; Terence Rooney; Douglas Schlichting; Stephanie de Bono; Paul Emery
Journal:  Ann Rheum Dis       Date:  2016-09-29       Impact factor: 19.103

6.  Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.

Authors:  Desirée van der Heijde; Maxime Dougados; Ying-Chou Chen; Maria Greenwald; Edit Drescher; Rena Klar; Li Xie; Inmaculada de la Torre; Terence P Rooney; Sarah L Witt; Douglas E Schlichting; Stephanie de Bono; Paul Emery
Journal:  RMD Open       Date:  2018-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.